References
- Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst. Rev.1, CD000181 (2007).
- O’Riordan TG. Inhaled antimicrobial therapy: from cystic fibrosis to the flu. Respir. Care45, 836–845 (2000).
- Klepser ME. Role of nebulized antibiotics for the treatment of respiratory infections. Curr. Opin. Infect. Dis.17, 109–112 (2004).
- Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit. Care10, R123 (2006).
- Falagas ME, Siempos II. Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract. Eur. Respir. J.31, 1138–1139 (2008).
- Ioannidou E, Siempos II, Falagas ME. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J. Antimicrob. Chemother.60, 1216–1226 (2007).
- Farber JE, Ross J. The use of aerosol penicillin and streptomycin in bronchopulmonary infections. Calif. Med.73, 214–217 (1950).
- Klastersky J, Geuning C, Mouawad E, Daneau D. Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest61, 117–120 (1972).
- McCall CY, Spruill WJ, Wade WE. The use of aerosolized tobramycin in the treatment of a resistant pseudomonal pneumonitis. Ther. Drug Monit.11, 692–695 (1989).
- Standridge JB, Aliff CL. Aerosolized amikacin in the treatment of Pseudomonas pneumonia in the nursing home setting. South Med. J.94, 244–246 (2001).
- Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit. Care9, R53–R59 (2005).
- Berlana D, Llop JM, Fort E, Badia MB, Jodar R. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am. J. Health Syst. Pharm.62, 39–47 (2005).
- Kwa AL, Loh C, Low JG, Kurup A, Tam VH. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis.41, 754–757 (2005).
- Larsson S, Svedmyr N. Bronchodilating effect and side effects of β2-adrenoceptor stimulants by different modes of administration. Am. Rev. Respir. Dis.116, 861–869 (1977).
- Falagas ME, Kasiakou SK. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Infection35, 3–10 (2007).
- Pines A, Raafat H, Plucinski K. Gentamicin and colistin in chronic purulent bronchial infections. BMJ2, 543–545 (1967).
- Michalopoulos A, Kasiakou SK, Falagas ME. The significance of different formulations of aerosolized colistin. Crit. Care9, 417–418 (2005).
- Dhand R. The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir. Care52, 866–884 (2007).
- Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am. J. Infect. Control3, 121–125 (1989).